標(biāo)題: Titlebook: Central Nervous System Leukemia; Prevention and Treat Renato Mastrangelo,David G. Poplack,Riccardo Ricca Book 1983 Martinus Nijhoff Publish [打印本頁(yè)] 作者: 傷害 時(shí)間: 2025-3-21 18:43
書(shū)目名稱Central Nervous System Leukemia影響因子(影響力)
書(shū)目名稱Central Nervous System Leukemia影響因子(影響力)學(xué)科排名
書(shū)目名稱Central Nervous System Leukemia網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱Central Nervous System Leukemia網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱Central Nervous System Leukemia被引頻次
書(shū)目名稱Central Nervous System Leukemia被引頻次學(xué)科排名
書(shū)目名稱Central Nervous System Leukemia年度引用
書(shū)目名稱Central Nervous System Leukemia年度引用學(xué)科排名
書(shū)目名稱Central Nervous System Leukemia讀者反饋
書(shū)目名稱Central Nervous System Leukemia讀者反饋學(xué)科排名
作者: chastise 時(shí)間: 2025-3-21 20:20
Central Nervous System Prophylaxis for Therapy of Acute Lymphocytic Leukemia,at cure is now a realistic goal of treatment (1). There has been increasing emphasis in recent years, therefore, on the late consequences of the disease and its therapy. These late consequences include possible organ damage, endocrine dysfunction, second malignancies, central nervous system (CNS) dy作者: 富饒 時(shí)間: 2025-3-22 01:46
Reduction in Central Nervous System Leukemia with a Pharmaco-kinetically derived Intrathecal-Methot that the primary volume of distribution of IT MTX approximated the extracellular-fluid volume of the central nervous system (CNS) (1). The modified dosage regimen was subsequently confirmed to be less neurotoxic (2), with more consistent cerebrospinal-fluid (CSF) MTX concentrations than dosage base作者: 紀(jì)念 時(shí)間: 2025-3-22 08:05 作者: Abduct 時(shí)間: 2025-3-22 12:18
,Prophylaxis of Central Nervous System Leukaemia: British Experience, 1970–80, the United Kingdom, one of the variables was ‘prophylactic’ treatment against central nervous system (CNS) leukaemia. In view of the overwhelming evidence for the efficacy of such treatment (1, 2), all patients entered to subsequent trials have received some form of CNS prophylaxis. This report com作者: evasive 時(shí)間: 2025-3-22 13:29
The Norwegian Methotrexate Study in Childhood Acute Lymphocytic Leukemia,elsewhere in this book, have indicated the potential adverse effects of the combination of cranial irradiation and intrathecal methotrexate. Therefore we have tried to avoid prophylactic cranial irradiation in our treatment protocol.作者: evasive 時(shí)間: 2025-3-22 18:14
Therapy Related Central Nervous System Diseases in Children with Acute Lymphocytic Leukemia,nally irradiation to enlarged viscera and mediastinal masses, the majority of children who developed this disease died during the first six months following diagnosis, and rarely did a child survive beyond nine months (1). Farber’s success, reported in 1948, in achieving temporary remissions in five作者: Prophylaxis 時(shí)間: 2025-3-23 00:18 作者: osculate 時(shí)間: 2025-3-23 03:21
Evaluation of Adverse Sequelae of Central Nervous System Prophylaxis in Acute Lymphoblastic Leukemin with acute lymphoblastic leukemia. Anatomic abnormalities (defined by CT brain scan), neuroendocrine damage, as well as neurological and intellectual dysfunction have all been reported in patients who have received central nervous system propylaxis, usually in the form of cranial radiation and int作者: cliche 時(shí)間: 2025-3-23 09:14 作者: 怎樣才咆哮 時(shí)間: 2025-3-23 12:22
Treatment of Overt CNS Leukaemia,roach of intrathecal Methotrexate (IT MTX) to clear the CSF of blast cells followed by craniospinal radiotherapy. In those randomized to have cranial only, rather than craniospinal, radiotherapy there was no comparable benefit; 8 out of 8 developing further CNS relapse. These results were obtained i作者: adhesive 時(shí)間: 2025-3-23 15:15 作者: Glucose 時(shí)間: 2025-3-23 18:52
Treatment of Meningeal Leukemia: Investigation of New Approaches with Conventional Agents,ority of cases, remission durations are usually short and most patients suffer subsequent relapse. A major barrier to the identification of successful chemotherapeutic approaches to the treatment of overt meningeal leukemia is the fact that only a few antineoplastic agents are appropriate for intrat作者: AVERT 時(shí)間: 2025-3-24 01:25
https://doi.org/10.1007/978-3-642-74938-4elsewhere in this book, have indicated the potential adverse effects of the combination of cranial irradiation and intrathecal methotrexate. Therefore we have tried to avoid prophylactic cranial irradiation in our treatment protocol.作者: Strength 時(shí)間: 2025-3-24 06:20 作者: ureter 時(shí)間: 2025-3-24 06:50 作者: 來(lái)這真柔軟 時(shí)間: 2025-3-24 13:52 作者: MOT 時(shí)間: 2025-3-24 18:15 作者: sed-rate 時(shí)間: 2025-3-24 21:40
https://doi.org/10.1007/978-3-642-74697-0Two principal methods have been employed for irradiating the brain, spinal cord, or both to prevent meningeal leukemia in children. The most common method is external beam irradiation, and the second is the instillation of radiocolloids in the subarachnoid space.作者: 運(yùn)動(dòng)性 時(shí)間: 2025-3-25 00:31 作者: antedate 時(shí)間: 2025-3-25 07:23 作者: Accessible 時(shí)間: 2025-3-25 11:14 作者: AGOG 時(shí)間: 2025-3-25 13:50
https://doi.org/10.1007/978-3-642-74678-9ely treated this disease progresses and produces characteristic anatomical sequelae and predictable clinical manifestations. This paper has reviewed these problems by examining a) the anatomy of the leptomeninges as it pertains to CNS leukemia, b) the sequence of events occurring during the histopat作者: 幻影 時(shí)間: 2025-3-25 17:21
https://doi.org/10.1007/978-3-642-74697-0at cure is now a realistic goal of treatment (1). There has been increasing emphasis in recent years, therefore, on the late consequences of the disease and its therapy. These late consequences include possible organ damage, endocrine dysfunction, second malignancies, central nervous system (CNS) dy作者: Atrium 時(shí)間: 2025-3-25 23:54
, Oncogenes in Chemical Carcinogenesis, that the primary volume of distribution of IT MTX approximated the extracellular-fluid volume of the central nervous system (CNS) (1). The modified dosage regimen was subsequently confirmed to be less neurotoxic (2), with more consistent cerebrospinal-fluid (CSF) MTX concentrations than dosage base作者: Prophylaxis 時(shí)間: 2025-3-26 03:16 作者: 考得 時(shí)間: 2025-3-26 05:38 作者: 搬運(yùn)工 時(shí)間: 2025-3-26 10:54 作者: 得罪人 時(shí)間: 2025-3-26 14:33 作者: MAUVE 時(shí)間: 2025-3-26 17:12 作者: 不可磨滅 時(shí)間: 2025-3-26 21:55 作者: STENT 時(shí)間: 2025-3-27 04:38
Signal Processing Fundamentals,agnosis. Critical to successful therapy is the prevention of clinically undetectable leukemic involvement of the Central Nervous System (CNS). Although multiple methods of CNS Preventive Therapy (CNS prophylaxis) have been attempted, craniospinal or cranial irradiation plus methotrexate (MTX) have b作者: Alienated 時(shí)間: 2025-3-27 05:16 作者: 貨物 時(shí)間: 2025-3-27 09:50
Siegfried Nolting,Hans Christian Kortinglow doses (e.g., about 450 rad) were employed; in any case, survival was poor because of high bone marrow relapse rates (1). This discussion will concentrate on the therapy of CNS leukemia in the modern era of successful chemotherapy for acute leukemia in childhood.作者: aggrieve 時(shí)間: 2025-3-27 13:37 作者: 制度 時(shí)間: 2025-3-27 18:47 作者: 壯觀的游行 時(shí)間: 2025-3-28 00:17 作者: 拱形面包 時(shí)間: 2025-3-28 03:08 作者: 細(xì)微差別 時(shí)間: 2025-3-28 07:36
Radiation Therapy Methods for the Treatment of Central Nervous System Leukemia,low doses (e.g., about 450 rad) were employed; in any case, survival was poor because of high bone marrow relapse rates (1). This discussion will concentrate on the therapy of CNS leukemia in the modern era of successful chemotherapy for acute leukemia in childhood.作者: 諷刺 時(shí)間: 2025-3-28 13:46 作者: 聲明 時(shí)間: 2025-3-28 15:53
Evaluation of Adverse Sequelae of Central Nervous System Prophylaxis in Acute Lymphoblastic Leukemiharacterize the adverse sequelae associated with CNS prophylaxis (1–3). The present report will summarize the findings of these studies and discuss their implications for the treatment of the patient with ALL.作者: Fissure 時(shí)間: 2025-3-28 22:21
Book 1983r 50% of children with this disease will be alive and free of their disease at least 5 years from the time of their initial diagnosis. Although a number of factors have contributed to this improvement, perhaps none has been as important as the institution of central nervous system preventive therapy作者: Debate 時(shí)間: 2025-3-29 01:52
Siegfried Nolting,Hans Christian Kortingto explore the possibility of utilizing alternative approaches with currently available chemotherapy. In this report we will discuss studies which we have undertaken with two currently available chemotherapeutic agents, cytosine arabinoside and L-asparaginase, in an attempt to define new approaches to the treatment of CNS leukemia.作者: champaign 時(shí)間: 2025-3-29 03:25
Treatment of Meningeal Leukemia: Investigation of New Approaches with Conventional Agents,to explore the possibility of utilizing alternative approaches with currently available chemotherapy. In this report we will discuss studies which we have undertaken with two currently available chemotherapeutic agents, cytosine arabinoside and L-asparaginase, in an attempt to define new approaches to the treatment of CNS leukemia.作者: gonioscopy 時(shí)間: 2025-3-29 07:56 作者: HAIRY 時(shí)間: 2025-3-29 15:04
https://doi.org/10.1007/978-3-642-74678-9hese problems by examining a) the anatomy of the leptomeninges as it pertains to CNS leukemia, b) the sequence of events occurring during the histopathogenesis of meningeal leukemia, and c) the histological sequelae and their resultant clinical manifestations.作者: 易受刺激 時(shí)間: 2025-3-29 16:18 作者: abracadabra 時(shí)間: 2025-3-29 20:23
, Oncogenes in Chemical Carcinogenesis,rapy, based on the CNS sanctuary theory, has been widely used and the results obtained with this approach have been discussed by D’Angio (2), Mauer (3), Bleyer (4) and Hardisty (5) elsewhere in this volume.作者: 襲擊 時(shí)間: 2025-3-30 03:57
Die Onychomykose-Therapie in der Praxis,dence for the efficacy of such treatment (1, 2), all patients entered to subsequent trials have received some form of CNS prophylaxis. This report compares the results to date of the various prophylactic regimes used in UKALL trials I–V, to which patients were entered between 1970 and 1979.作者: 小卷發(fā) 時(shí)間: 2025-3-30 05:47 作者: 良心 時(shí)間: 2025-3-30 09:39
The Pathology of Central Nervous System Leukemia,hese problems by examining a) the anatomy of the leptomeninges as it pertains to CNS leukemia, b) the sequence of events occurring during the histopathogenesis of meningeal leukemia, and c) the histological sequelae and their resultant clinical manifestations.作者: 無(wú)目標(biāo) 時(shí)間: 2025-3-30 14:06
Reduction in Central Nervous System Leukemia with a Pharmaco-kinetically derived Intrathecal-Methotosage regimen was subsequently confirmed to be less neurotoxic (2), with more consistent cerebrospinal-fluid (CSF) MTX concentrations than dosage based on body surface area (2, 3). Whether or not the altered dose schedule provided enhanced therapeutic benefit remained to be established.作者: 脆弱么 時(shí)間: 2025-3-30 16:49 作者: 相反放置 時(shí)間: 2025-3-30 22:37
,Prophylaxis of Central Nervous System Leukaemia: British Experience, 1970–80,dence for the efficacy of such treatment (1, 2), all patients entered to subsequent trials have received some form of CNS prophylaxis. This report compares the results to date of the various prophylactic regimes used in UKALL trials I–V, to which patients were entered between 1970 and 1979.作者: Gentry 時(shí)間: 2025-3-31 03:01 作者: 直覺(jué)好 時(shí)間: 2025-3-31 08:27 作者: meritorious 時(shí)間: 2025-3-31 09:37
